Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

BMS-986466

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

BMS, BridgeBio, LianBio

Drug class:

PTPN11 inhibitor

Related drugs:

KRAS G12C	Non Small Cell Lung Cancer	KRAS G12C	Non Small Cell Lung Cancer	sotorasib + BMS-986466 Sensitive: B - Late Trials sotorasib + BMS-986466 Sensitive : B	sotorasib + BMS-986466 Sensitive: B - Late Trials sotorasib + BMS-986466 Sensitive : B
EGFR mutation	Non Small Cell Lung Cancer	EGFR mutation	Non Small Cell Lung Cancer	BMS-986466 Sensitive: C2 – Inclusion Criteria BMS-986466 Sensitive : C2	BMS-986466 Sensitive: C2 – Inclusion Criteria BMS-986466 Sensitive : C2
EGFR mutation	Non Small Cell Lung Cancer	EGFR mutation	Non Small Cell Lung Cancer	osimertinib + BMS-986466 Sensitive: D – Preclinical osimertinib + BMS-986466 Sensitive : D	osimertinib + BMS-986466 Sensitive: D – Preclinical osimertinib + BMS-986466 Sensitive : D